DARE Research and Charts

DARE - Dare Bioscience Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2026-02-10)

Last 1.69	Change ⇓ -0.02 (-1.17%)	Volume 68,162
	Open 1.71	High 1.74	Low 1.68

8EMA (Daily) 1.74	40EMA (Daily) 1.90	50EMA (Daily) 1.91	STO (Daily) 8.084	MACD Hist (Daily) -0.014
8EMA (Weekly) 1.846	40EMA (Weekly) 2.16	50EMA (Weekly) 2.21	STO (Weekly) 21.935	MACD Hist (Weekly) -0.020


Company Profile
Dare Bioscience Inc is a clinical-stage biopharmaceutical company focused on women's reproductive health. The products of the company are related to contraception, vaginal health, sexual health and fertility. Ovaprene is a product designed by the company to provide multiple weeks of contraceptive protection without the use of hormones.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.